Ads
related to: Acute Myeloid Leukemia
Search results
Red carpet with a cause: This fashion show fundraiser helps kids with cancer
The Record· 3 days agoIt is now a life purpose for Paula Corrieri, of Wayne, whose 15-year-old son, Rocco Sivolella, died...
bluebird bio reports first commercial gene therapy use By Investing.com
Investing.com· 5 days agoThis development marks a major step in making the treatment accessible to patients with a history of...
2 Incredible Growth Stocks to Buy Hand Over Fist
Motley Fool via Yahoo Finance· 4 days agoThis novel oral treatment for leukemia has the potential to surpass $1 billion in sales if it secures regulatory nods in both the front- and later-line...
Apollomics shares target cut on Phase 3 study results By Investing.com
Investing.com· 3 days agoThe adjustment came in response to recently revealed Phase 3 study results which did not meet the...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript May 7, 2024 Rigel...
GlycoMimetics fails phase 3 blood cancer trial, causing investors to sour on stock
FierceBiotech· 6 days agoMonday, GlycoMimetics reported the failure of the trial—spurring a 72% stock drop that crushed the company's share price to 51 cents in premarket trading Monday morning, compared to $1.83 at ...
Curis to Present Updated Data from the TakeAim Leukemia Study
WPRI Providence· 2 days agoCuris, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company ...
Why Is GlycoMimetics (GLYC) Stock Down 77% Today?
InvestorPlace· 5 days agoGlycoMimetics (NASDAQ:GLYC) stock is taking a beating on Monday after the biotechnology company announced results from a Phase 3 clinical trial....
TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
Morningstar· 5 days agoTC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today ...
To my late mom on Mother's Day: I miss you and hope you'd be proud | Anna Snyder
The Tuscaloosa News· 4 days agoAnna Snyder's mom passed away nearly 2 years ago. Here is her love letter on Mother's Day to the...
